Editorial: The microbiome in the development of gastrointestinal diseases

Editorial: The microbiome in the development of gastrointestinal diseases

Opis bibliograficzny
Główni autorzy:	Amedeo Amedei, Ralf Weiskirchen
Format:	Artykuł
Język:	English
Wydane:	Frontiers Media S.A. 2025-03-01
Seria:	Frontiers in Cellular and Infection Microbiology
Hasła przedmiotowe:	microbiome gastrointestinal disease MAFLD inflammatory bowel disease colorectal cancer dysbiosis
Dostęp online:	https://www.frontiersin.org/articles/10.3389/fcimb.2025.1561143/full

Podobne zapisy

The microbiome in inflammatory bowel diseases: from pathogenesis to therapy
od: Sheng Liu, i wsp.
Wydane: (2020-06-01)

The intestinal microbiome of inflammatory bowel disease across the pediatric age range
od: Máire A. Conrad, i wsp.
Wydane: (2024-12-01)

The microbiome landscape in pediatric Crohn’s disease and therapeutic implications
od: Karin Fetter, i wsp.
Wydane: (2023-12-01)

Editorial: The mechanism of immune cells in the development of inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CAC)
od: Edda Russo, i wsp.
Wydane: (2023-05-01)

Dietary Regulation of the Crosstalk between Gut Microbiome and Immune Response in Inflammatory Bowel Disease
od: Qianqian Yao, i wsp.
Wydane: (2021-02-01)

Pathogenic role of the gut microbiota in gastrointestinal diseases
od: Hiroko Nagao-Kitamoto, i wsp.
Wydane: (2016-04-01)

Editorial: Understanding molecular mechanisms to facilitate the development of biomarkers for therapeutic intervention in gastrointestinal diseases and sepsis
od: Dipak Kumar Sahoo, i wsp.
Wydane: (2025-03-01)

The effects of dairy on the gut microbiome and symptoms in gastrointestinal disease cohorts: a systematic review
od: Clíona Ní Chonnacháin, i wsp.
Wydane: (2024-01-01)

Editorial: Gut Microbiota and Inflammation: Relevance in Cancer and Cardiovascular Disease
od: Cinzia Parolini, i wsp.
Wydane: (2020-12-01)

The Oral Microbiome in Pediatric IBD: A Source of Pathobionts or Biomarkers?
od: Khalid Elmaghrawy, i wsp.
Wydane: (2021-01-01)

Gut Microbiome as a Target of Intervention in Inflammatory Bowel Disease Pathogenesis and Therapy
od: Helal F. Hetta, i wsp.
Wydane: (2024-10-01)

The Human Gut Microbiome – A Potential Controller of Wellness and Disease
od: Zhi Y. Kho, i wsp.
Wydane: (2018-08-01)

Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease
od: Hengameh Chloé Mirsepasi-Lauridsen, i wsp.
Wydane: (2018-11-01)

Hydrogen Sulfide Effects on the Survival of Lactobacilli with Emphasis on the Development of Inflammatory Bowel Diseases
od: Ivan Kushkevych, i wsp.
Wydane: (2019-11-01)

Genetic and causal relationship between chronic gastrointestinal diseases and erectile dysfunction: a Mendelian randomization study
od: Xiaoyan Zeng, i wsp.
Wydane: (2024-07-01)

D-Lactate: Implications for Gastrointestinal Diseases
od: Barblin Remund, i wsp.
Wydane: (2023-05-01)

Ghrelin in Focus: Dissecting Its Critical Roles in Gastrointestinal Pathologies and Therapies
od: Wei Wu, i wsp.
Wydane: (2024-01-01)

Gastrointestinal microbiome and coronavirus disease: evidence of a bidirectional association
od: Kevin V. Houston, i wsp.
Wydane: (2023-04-01)

Gastrointestinal Tuberculosis Mimicking Crohn’s Disease
od: Maria Ana Rafael, i wsp.
Wydane: (2019-12-01)

Gastrointestinal microbiome, what is behind faecal microbiota transplantation?
od: P. Thomson, i wsp.
Wydane: (2021-07-01)

Microbiome, Metabolome and Inflammatory Bowel Disease
od: Ishfaq Ahmed, i wsp.
Wydane: (2016-06-01)

The Reg protein family: potential new targets for the treatment of inflammatory bowel disease and colorectal cancer
od: Anqi Yao, i wsp.
Wydane: (2024-09-01)

Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity
od: P. R. Sternes, i wsp.
Wydane: (2022-07-01)

CORRELATION BETWEEN IBD, INTESTINAL DYSBIOSIS, DIET AND MOOD TONE DISEASE: ANALYSIS OF LITERATURE
od: Giorgio Maida
Wydane: (2022-12-01)

Homeostasis and Dysbiosis of the Intestinal Microbiota: Comparing Hallmarks of a Healthy State with Changes in Inflammatory Bowel Disease
od: Jasminka Talapko, i wsp.
Wydane: (2022-12-01)

Cardiovascular Diseases and Pharmacomicrobiomics: A Perspective on Possible Treatment Relevance
od: Lavinia Curini, i wsp.
Wydane: (2021-09-01)

Editorial: Epigenetics of inflammatory reactions and pharmacological modulation
od: Amedeo Amedei, i wsp.
Wydane: (2024-10-01)

Emerging trends and research foci in gastrointestinal microbiome
od: Xiaoquan Huang, i wsp.
Wydane: (2019-02-01)

Editorial: Reviews in microbiome in health & disease
od: Suhana Chattopadhyay, i wsp.
Wydane: (2024-05-01)

The oral microbiome and oral and upper gastrointestinal diseases
od: Sifan Liu, i wsp.
Wydane: (2024-12-01)

Pollutants, microbiota and immune system: frenemies within the gut
od: Pierluigi Rio, i wsp.
Wydane: (2024-05-01)

Colorectal Cancer in Patient with Functional Gastrointestinal Symptoms
od: Z. A. Mamieva, i wsp.
Wydane: (2022-01-01)

Nutritional Intake and Gut Microbiome Composition Predict Parkinson’s Disease
od: Michal Lubomski, i wsp.
Wydane: (2022-05-01)

MAIT cells and the microbiome
od: Maisha F. Jabeen, i wsp.
Wydane: (2023-02-01)

Role of human microbiota in the development of colorectal cancer
od: S. O. Kochkina, i wsp.
Wydane: (2019-10-01)

Gut microbiota therapy in gastrointestinal diseases
od: Hanif Ullah, i wsp.
Wydane: (2025-02-01)

Editorial: The Microbiome in Hepatobiliary and Intestinal Disease
od: Phillipp Hartmann, i wsp.
Wydane: (2022-04-01)

Molecular mechanisms of intestinal inflammation leading to colorectal cancer
od: Sonia Shastri, i wsp.
Wydane: (2017-02-01)

Studying the Enteric Microbiome in Inflammatory Bowel Diseases: Getting through the growing pains and moving forward
od: Vincent B Young, i wsp.
Wydane: (2011-07-01)

The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
od: Erica Jennison, i wsp.
Wydane: (2021-01-01)